Two-thirds of the way through fiscal year 2017, the FDA has received at least 877 ANDAs, passing fiscal 2016’s total of 852 and beating fiscal 2015’s total by more than…

The FDA is proposing an experimental study to examine the effects of risk disclosures and fine print in direct-to-consumer drug advertising. Source: Drug Industry Daily

The European Medicines Agency has decided to postpone the implementation of its Clinical Trials Regulation from October of next year to 2019 at the earliest, due to technical difficulties. Source:…

A trio of individual pharmaceutical recalls swept through the industry last week, spotlighting a variety of formulation and quality control issues at major drugmakers. Source: Drug Industry Daily

Nevada’s landmark plan requiring insulin manufacturers to disclose price information was signed into law last week, establishing a more targeted strategy compared to the broader price transparency legislation currently being…